drugset / Trial / NCT02432885
Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial
Phase 3
Completed
76 enrolled
InCor Heart Institute
Federal University of Minas Gerais · collabUniversity of Sao Paulo · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial intends to evaluate myocardial Fibrosis progression in Duchenne and Becker Muscular Dystrophy, as well the influence of ACE inhibitors in fibrosis progression. Additionally, this study aims to determine genetic predictors of cardiac involvement in these dystrophies.
Timeline
- Start
- 2009-06
- Primary completion
- 2012-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enalapril | Other / unclassified | 20 mg | — |